Canadian scientists have begun to prepare medicines from genetically modified organisms (GMOs). In particular, Canadian researchers from the company SubTerra have high hopes for two of them from the legume family - lupine and wood sorrel. From genetically modified plants, scientists plan to extract an enzyme capable of overcoming severe combined immunodeficiency (SCID), also known as bubble boy syndrome, alymphocytosis or Glanzmann-Rinicker syndrome.